Mind Medicine (also generally recognized as MindMed) was the primary psychedelic drugmaker to conduct an initial public providing (IPO), on Canada’s NEO Exchange in March 2020. The company had been founded less than a yr earlier, in May 2019. The drugmaker is currently conducting two phase 3 studies evaluating COMP360 in treatment-resistant depression. Resul...